Tirzepatide: Dual GIP and GLP-1 Activation Tirzepatide activates two appetite-related hormone signals instead of one
What are the minimum deductible amounts for HDHPs in 2025
Cardiovascular, mortality, and kidney outcomes with Glp-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Any Cigna coverage for Zepbound is evaluated using the same criteria as Wegovy, and just like Wegovy, prior authorization is required
If you have diabetes risk factors, this needs to be monitored carefully
monitor renal function when initiating or escalating doses of semaglutide in patients reporting severe adverse gastrointestinal reactions Pregnancy-Lactation Pregnancy Data are limited regarding use in pregnant women Based on animal reproduction studies, there may be potential risks to the fetus from exposure to semaglutide during pregnancy